Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group

被引：0

作者：

J. Aparicio

X. García del Muro

P. Maroto

J. Terrasa

D. Castellano

R. Bastús

J. Gumà

N. Sagastibeltza

I. Durán

S. Ochenduszko

J. A. Meana

J. García-Sánchez

J. A. Arranz

R. Gironés

J. R. Germà

机构：

[1] Hospital Universitario y Politécnico La Fe,Servicio de Oncología Médica

[2] University of Barcelona,Institut Catalá d’Oncologia Hospitalet, IDIBELL

[3] Hospital de la Santa Creu i Sant Pau,undefined

[4] Hospital Universitario Son Espases,undefined

[5] Hospital Universitario 12 de Octubre,undefined

[6] Hospital Universitari Mútua Terrassa,undefined

[7] Hospital Universitari Sant Joan,undefined

[8] URV,undefined

[9] IISPV,undefined

[10] Hospital Universitario Donostia,undefined

[11] Hospital Universitario Marqués de Valdecilla,undefined

[12] Hospital Universitario Doctor Peset,undefined

[13] Hospital General Universitario,undefined

[14] Hospital Arnau de Vilanova,undefined

[15] Hospital Universitario Gregorio Marañón,undefined

来源：

Clinical and Translational Oncology | 2021年 / 23卷

关键词：

Seminoma; Surveillance; Adjuvant chemotherapy; Relapses;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：58 / 64

页数：6

共 33 条

[1]

Honecker F(2018)ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up Ann Oncol 29 1658-1686

[2]

Aparicio J(2014)A nationwide cohort study of stage I seminoma patients followed on a surveillance program Eur Urol 66 1172-1178

[3]

Berney D(2015)Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance J Clin Oncol 33 51-57

[4]

Mortensen MS(2017)Outcome of men with relapse after adjuvant carboplatin for clinical stage I seminoma J Clin Oncol 35 194-200

[5]

Lauritsen J(2003)Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma Ann Oncol 14 867-872

[6]

Gundgaard MG(2005)Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study J Clin Oncol 23 8717-8723

[7]

Kollmannsberger C(2011)Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study J Clin Oncol 29 4677-4681

[8]

Tandstad T(2018)A risk-adapted approach to patients with stage I seminoma according to the status of rete testis: the Fourth Spanish Germ Cell Cancer Group Study Oncology 95 8-12

[9]

Bedard PL(1997)International germ cell consensus classification: a prognostic factor based staging system for metastatic germ cell cancers J Clin Oncol 15 594-603

[10]

Fischer S(2011)Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up J Natl Cancer Inst 103 241-249

← 1 2 3 4 →